NTI receives SBIR grant funding from the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to develop a multiplex protein and microRNA biomarker-based test for protease activity profiling in arthritic joints which should prove highly useful for drug development and personalized treatments.